The International Paediatric Onco-Critical Care Symposium (IPOCCS) brings together international experts to discuss current challenges and advances in the field of paediatric onco-critical care. The goal of this symposium is to advance the care of critically ill paediatric haematology/oncology patients through improvements in patient care, multidisciplinary collaboration, as well as clinical and translational research.
IPOCCS is organized in collaboration by St. Jude Children’s Research Hospital, Great Ormond Street Hospital for Children, and the Princess Máxima Center for Pediatric Oncology.
-
In-Person Registration
In-person registration provides access to all on-site sessions and experiences at IPOCCS.
In addition, all in-person attendees will receive full access to the IPOCCS virtual platform, allowing you to view select sessions live and access on-demand recordings and digital content during and following the conference.
Virtual Registration
Virtual registration grants access to the IPOCCS virtual platform for remote participation, including live-streamed sessions (when available), on-demand session recordings, and select digital conference content.
This registration type is intended for virtual participation only and does not include access to the in-person meeting or on-site programming.
Fees
Registration Type In-Person Virtual Physicians, Advanced Practice Providers, Nurses, and Respiratory Therapists
- $300 until March 13, 2026
- $500 after March 13
- $250 until March 13
- $400 after March 13
Medical Trainees (Students, Residents, Fellows)
- $200 until March 13
- $250 after March 13
- $150 until March 13
- $200 after March 13
Low to Middle Income Countries (LMIC) attendees
- $25
- $25
St. Jude Children's Research Hospital and Le Bonheur Children's Hospital employees and trainees
- $100
- $100
Core Concepts in Onco-Critical Care Pre-Conference Event (Tuesday, April 14)*
- $50 general
- $15 LMIC
- $50 general
- $15 LMIC
Core Concepts in Onco-Critical Care Pre-Conference Event: Tuesday, April 14
This educational pre-day will describe current literature and management of oncologic specific emergencies in critical care in all potential settings (including middle- and lower-income settings) and outline key differences between critically ill oncologic patients and critically ill general pediatric patients. Sessions will be lectures followed by expert panel discussion. Please bring all your questions!
This can be added to your registration by selecting “Core Concepts of Onco-Critical Care” prior to checkout. The detailed agenda is included under the “Agenda” tab.
-
Hotel
The Peabody Memphis is the official hotel for the International Paediatric Onco-Critical Care Symposium. A special room block has been reserved at a rate of $240 per night.
Transportation
Transportation will be provided from The Peabody to St. Jude campus and back. Attendees staying at other hotels should plan to meet at The Peabody to take the shuttle. Please note that personal vehicles are not permitted on campus.
-
Tuesday, April 14
Core Concepts in Onco-Critical Care
Time Event/Session 8:45-9:00 am Welcome
- Melissa Hines, MD
- Caitlin Hurley, MD
9:00-9:45 am Respiratory Failure in Onco-Critical Care
- Courtney Rowan, MD
9:45-10:30 am Neutropenic Sepsis
- Gaby Maron, MD
10:30-10:45 am Break 10:45-11:30 am Literature Review for Pediatric Onco-Critical Care: Studies That Have Changed Our Practice and Research
- Melissa Hines, MD
- Roelie Wösten-van Asperen, MD, PhD
11:30 am-12:15 pm Oncologic Emergencies at Leukemia Diagnosis
- Jennifer McArthur, DO
- Hannah Estes, MD
12:15-1:30 pm Lunch 1:30-3:00 pm Session A
Development of a Vascular Access Team
- Stephenie Morgan, BSN, RN, CPN, VA-BC
- Darenda Wright, BSN, RN, CPN, VA-BC
1:30-2:45 pm Session B
ECMO in the Onco-Critical Care Population
- Saad Ghafoor, MD
- Matteo Di Nardo, MD
3:00-4:15 pm Difficult Cases
Navigating Diffuse Alveolar Haemorrhage in Paediatric Onco-Critical Care Unit: Insights from a Resource-Constrained Setting
- Parthasarathi Bhattacharyya, MD
Severe PARDS as the Initial Presentation of Occult Anaplastic Large Cell T-Cell Lymphoma in an Adolescent
- Priscila Rodrigues, MD
Wednesday, April 15
Time Event/Session 8:45-9:00 am Welcome
- Melissa Hines, MD
- Caitlin Hurley, MD
9:00-10:00 am Keynote Presentation
Genomic Studies in Pediatric Critical Illness: Approaches, Clinical Significance and Relevance to Pediatric Onco-Critical Care
- Heidi Flori, MD, FAAP
- Mary K. Dahmer, PhD
10:00-10:15 am Break 10:15-10:45 am Chronic Pulmonary Complications After Hematopoietic Stem Cell Transplantation
- Gregory Yanik, MD
10:45-11:15 am Lung Transplantation after Pediatric Hematopoietic Stem Cell Transplantation: Role and Considerations
- Shailendra Das, DO
11:15-11:30 am Break 11:30 am-12:00 pm The Impact of Infectious Diseases for Pediatric Onco-Critical Care Patients in a World of Declining Vaccine Uptake
- Richard Webby, PhD
11:30 am-12:00 pm Nursing Session
Machine AI Learning in Nursing
- Ahmed Said, MD, PhD
12:00-1:15 pm Lunch 1:15-2:30 pm Session A
Panel Discussion: Interdisciplinary Approach to Clinical Research on Genetic Differences in Pediatric Onco-Critical Care
- Mary K. Dahmer, PhD
- Heidi Flori, MD, FAAP
- Jennifer McArthur, DO
- Meaghan Weaver, MD, PhD
Session B: Global Difficult Cases
Tracheal Injury in a Patient with Lymphoma
- Luis Llano, MD
TA-TMA triggered by Dengue
- Izabelle Neves, MD
2:30-2:45 pm Break 2:45-3:45 pm Oral Abstract Presentations
Acute critical illness and resource utilization in children with cancer and sickle cell disease in resource-limited settings: a secondary analysis from the Global PARITY Study
- Eliana Lopez-Baron, MD
Identification of Capacity and Quality Indicators for Continuous Renal Replacement Therapy in Pediatric Oncology Patients
- Hannah Rees, MD
Respiratory Organ Dysfunction Criteria for Children with Cancer and Post-Hematopoietic Cell Transplantation: A Systematic Review
- Benjamin Oelkers, BS
Severe PARDS as the Initial Presentation of Occult Anaplastic Large Cell T-Cell Lymphoma in an Adolescent
- Priscila Rodrigues, MD
2:45-4:15 pm Nursing Session
Veno-occlusive Disease (VOD)
- Kathleen Maloney, PNP
3:45-4:15 pm Poster Presentation Announcements 4:00-4:15 pm Break 4:15-5:45 pm Abstract Session – for in-person attendees only Thursday, April 16
Time Event/Session 8:00-9:00 am Grand Rounds
The Role of Plasmapheresis in Sepsis: Lessons from Adult Critical Care, Future Directions and Special Considerations in Immunocompromised Sepsis
- L. Keith Scott, MD, MSc, FCCM
9:00-9:15 am Break 9:15-10:15 am Role Machine Learning and Artificial Intelligence in Pediatric Critical Care
- Ahmed Said, MD, PhD
Panel Discussion: How to Leverage Machine Learning and AI Methods in Pediatric Onco-Critical Care
- Hyun Jung (HJ) Park, PhD
- Ahmed Said, MD, PhD
- Melissa Hines, MD
- Jennifer McArthur, DO
9:15-10:15 am Nursing Session
Difficult Cases
- Laurie Shoulders, MS, MSN, RN, CCRN, CPHON
- Nieske van Beek, RN, CPON, PICU
10:15-10:30 am Break 10:30-11:00 am Advances in Therapy for Infants with Brain Tumors
- Aditi Bagchi, MD, PhD
10:30-11:45 am Nursing Session
SNAP into Action: Development & Implementation of Serial Neurological Assessment in Pediatrics Tool
- Katie A. Smith, DNP, MHP, ACCNS-P, CPN, CHES
11:00-11:30 am
Role of Virtual Reality and 3D Modeling in the Patient Family Experience and Palliative Care in Pediatric Oncology and Critical Care- Zach Abramson, DMD, MD
11:30 am-1:00 pm Lunch 1:00-1:30 pm Advances in Interventional Radiology in Pediatric Onco-Critical Care
- Allison Aguado, MD
1:30-2:15 pm Round Table Discussion: Role of Pheresis in TMA
- Saad Ghafoor, MD
- Nabil Tabish, MD, MS
2:15-2:30 pm Break 2:30-3:15 pm Debate: Role of Specialized ICU v. General PICU
- R. Ray Morrison, MD
- Joe Brierley, MD
3:15-3:30 pm Abstract Awards, IPOCCS Lifetime Achievement Award, Announcements, and Closing Remarks
- Joe Brierley, MD
- Melissa Hines, MD
- Caitlin Hurley, MD
- Roelie Wösten-van Asperen, MD, PhD
-
Abstracts must be submitted by 11:59 p.m. CST, on January 26, 2026. Abstract submissions will be evaluated anonymously and scored by the appropriate IPOCCS Abstract Committee. Full information about the abstract submission and selection process are included on the submission website.
If you have been selected to present an e-poster or an oral presentation, both of which are in person, please follow these instructions. You should have received an email confirming this status.
E-posters
- Format: horizontal (PowerPoint slide format).
- All posters (except oral abstracts and oral “difficult cases” presentations) will rotate on some of the monitors during the event.
- They will also be available on the virtual site/mobile app.
- During the poster session/reception, presenters will have a designated time to stand by their poster monitor and briefly present their work.
- Width: 13.33 inches (33.87 cm)
- Height: 7.5 inches (19.05 cm)
You may design your poster using this slide size and then export the final version as a JPG file (maximum 20 MB) when submitting.
As a reminder, we recommend the following font sizes to ensure readability on the display screens:
- Title: 60–80 pt
- Section headings: 36–44 pt
- Body text: 24–32 pt
Presentation timing during the poster session:
- Top poster presenters: 10 minutes presentation + 2–5 minutes Q&A.
- Other poster presenters: 8 minutes presentation + 2 minutes Q&A.
The abstract leadership team will assign presentation slots for the monitors.
Deadline: March 27, 2026
Oral Presentations
- These correspond to the abstracts selected for oral presentation.
- Oral presenters do not need to submit an additional e-poster.
- There is no required slide template .
- Top poster oral presentations: 10 minutes presentation + 5 minutes Q&A.
Difficult Cases Sessions
- Presenters who originally had an e-poster but are now presenting a 30-minute “difficult cases” session do not need to submit an e-poster.
If you have additional questions, please email poccs@stjude.org.
-
Educational Objectives and Outcomes
After attending this educational symposium, you should be able to:
- Determine which latest developments in pediatric onco-critical care are applicable to your practice
- Plan ways to implement those developments and strategies
Accreditation Statement
St. Jude Children’s Research Hospital is accredited by the ACCME to provide continuing medical education for physicians.
St. Jude Children’s Research Hospital is accredited as a provider of nursing continuing development by the American Nurses Credentialing Center’s Commission on Accreditation.
Credit Designation
St. Jude Children’s Research Hospital designates this live activity for a maximum of 15.00 AMA PRA Category 1 CreditsTM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Nurses and eligible attendees may claim up to 4.75 ANCC NCPD Contact Hours. Hours earned are commensurate with attendance and participation in a session.
Evaluation and Claiming Certificates
To claim AMA PRA Category 1 CreditTM, Nursing Continuing Professional Development Credit, or attendance credit for this activity, you must attend the sessions, complete the evaluation, and follow the instructions at the end of the evaluation to claim your credit. If you have questions about claiming your CME, ANCC NCPD, or attendance certificate, please contact us at cme@stjude.org. The evaluation will be open until July 17, 2026; you will not be able to claim credit after the evaluation is closed.
To receive ANCC NCPD Contact Hours for a session, attendees must:
- Arrive no later than 5 minutes after the start time of a session,
- Stay until the end of the session,
- Participate in any activities during the session,
- Complete the symposium assessment, and
- Claim your ANCC NCPD Contact Hours no later than July 17, 2026.
Disclosure of Financial Relationships
All individuals in a position to control the content of this CE activity (such as faculty, presenters, and planners) were asked to complete a statement regarding all financial relationships between themselves and any ineligible company (defined by the ACCME as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients).
All relevant relationships are disclosed below and have been mitigated; no other speakers, planners, or other individuals with control over content have disclosed relevant financial relationships with ineligible companies.
Dr. Melissa Hines has received grant/research support from Incyte and is a consultant for SOBI and Novartis.
Dr. Gabriela Maron is an advisor and has received grant/research support from Symbio Pharmaceuticals.
Dr. Nabil Tabish is an advisor for Novartis.
Dr. Richard Webby has received royalties or is a patent beneficiary from CIDARA.